CIK 0001604191 · Non-accelerated filer<br>Smaller reporting company
GridAI Technologies Corp.
Sign in to watch- Ticker
- GRDX
- Exchange
- Nasdaq
- Industry
- Electric & Other Services Combined
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464993860
- Phone
- 561-589-7020
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL
- Former names
- Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-16 | Pennington James CHIEF MEDICAL OFFICER | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2020-07-16 | BORKOWSKI EDWARD Director | Grant or award · Series B Convertible Preferred Stock | +46.12 | 46.12 | ||
| 2020-07-16 | BORKOWSKI EDWARD Director | Grant or award · Series B Warrants | +230,602 | 230,602 | ||
| 2020-07-16 | BORKOWSKI EDWARD Director | Grant or award · Exchange Warrants | +25,774 | 25,774 | ||
| 2020-07-16 | BORKOWSKI EDWARD Director | Returned to the company · 9.0% Senior Convertible Promissory Note | −100,000 | 0 | ||
| 2020-07-16 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Other disposition · Stock option (right to buy) | −35,006 | 300,000 | ||
| 2020-07-16 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Grant or award · Stock option (right to buy) | +35,006 | 35,006 | ||
| 2020-07-16 | Schneiderman Daniel H CHIEF FINANCIAL OFFICER | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | ||
| 2020-07-16 | SAPIRSTEIN JAMES PRESIDENT AND CEO | Grant or award · Stock options (right to buy) | +1,200,000 | 1,200,000 | ||
| 2020-07-16 | SAPIRSTEIN JAMES PRESIDENT AND CEO | Grant or award · Series B Convertible Preferred Stock | +12.99 | 12.99 | ||
| 2020-07-16 | SAPIRSTEIN JAMES PRESIDENT AND CEO | Grant or award · Series B Warrants | +64,935 | 64,935 | ||
| 2020-06-01 | BORKOWSKI EDWARD Director | Returned to the company · 9.0% Senior Convertible Promissory Note | −0 | $100,000.00 | $0 | 0 |
| 2020-06-01 | BORKOWSKI EDWARD Director | Grant or award · 9.0% Senior Convertible Promissory Note | +0 | $100,000.00 | $0 | |
| 2020-04-13 | Oakes Gregory Director | Grant or award · Options | +60,000 | 60,000 | ||
| 2020-04-06 | CASAMENTO CHARLES J Director | Grant or award · Options | +80,000 | 80,000 | ||
| 2020-04-06 | Schramm Vern Lee Director | Grant or award · Options | +80,000 | 80,000 | ||
| 2020-04-06 | Riddell Alastair Director | Grant or award · Options | +80,000 | 80,000 | ||
| 2020-04-06 | Spoor Johan M. Director | Grant or award · Options | +80,000 | 80,000 | ||
| 2020-04-06 | BORKOWSKI EDWARD Director | Grant or award · Options | +80,000 | 80,000 | ||
| 2020-03-19 | CASAMENTO CHARLES J Director | Gift | −9,000 | 107,998 |
Page 5 of 7 · 136 trades